Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
FDA’s approval of Opill, the first over-the-counter daily oral contraceptive, marks a major shift in contraceptive accessibility, opening new pathways in the prevention of unintended pregnancies.
Family Medicine/General Practice July 20th 2023
The New England Journal of Medicine
Explore the novel findings of a phase 2 trial on the tri-agonist retatrutide, demonstrating substantial weight reductions in adults with obesity over a 48-week period.
Endocrinology, Diabetes, Metabolism July 5th 2023
MDLinx
Explore the benefits of time-restricted eating, a diet pattern that suggests fewer, regular meals and fasting periods could improve insulin resistance, brain health, and glycemic control, potentially reducing the risk of developing type 2 diabetes and obesity.
Endocrinology, Diabetes, Metabolism June 29th 2023
Healthgrades for Professionals
With research hinting at potential links between vitamin B6 and various health benefits, it’s time for physicians to delve deeper into the role of this micronutrient in optimizing patient health.
Cardiology June 28th 2023
ReachMD
Explore the fascinating field of obesity management, where pharmacological treatments are combined with lifestyle modifications, to find out how doctors are reversing the trend in the fight against this epidemic on a global scale.
Endocrinology, Diabetes, Metabolism June 21st 2023
British Medical Journal (The BMJ)
Explore how metformin, a widely accessible diabetes drug, might play a critical role in preventing long COVID when given during the acute phase of COVID-19.
Allergy & Immunology June 21st 2023